Latest Breaking News On - North american antiepileptic drug - Page 1 : comparemela.com

Jazz Pharmaceuticals to Showcase Expansive Neuroscience Portfolio at American Academy of Neurology Annual Meeting

Jazz Pharmaceuticals to Showcase Expansive Neuroscience Portfolio at American Academy of Neurology Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomNew zealandUnited statesGreat britainKristin bhavnaniEpidiolex epidyolexAndrean flynnRob iannoneEuropean unionAccess programPregnancy surveillance programEuropean commissionExchange commissionTherapeutic goods administrationWorld idiopathic hypersomnia total health modelRegulatory agency

SK Life Science Publishes Updated Real-World Experience on Cenobamate in Epilepsia Based on Recent 100,000 Patient Exposure Milestone

/PRNewswire/ SK Life Science, Inc., a subsidiary of SK Biopharmaceuticals Co., Ltd., a global biotech focused on developing treatments for central nervous.

United kingdomUnited statesDexcel pharmaAngelini pharmaLouis ferrariWilliame rosenfeldMarc kaminSk life science incEuropean unionSk biopharmaceuticals co ltdSk life science labDrug administrationSk incSk groupEndo internationalSource sk life science inc

Jazz Pharmaceuticals to Present Long-Term and Real-World Data Emphasizing Commitment to Treatment-Resistant Epilepsy at the 2023 American Epilepsy Society Annual Meeting

/PRNewswire/ Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that nine company-sponsored presentations, including five late-breaking abstracts, will.

United statesUnited kingdomCounty south dublinGreat britainAndrean flynnKelvin tanKristin bhavnaniAccess programNational institute of neurological disordersAmerican epilepsy societyArts allianceEpilepsy foundationTuberous sclerosis allianceEuropean medicines agencyRegulatory agencyDrug administration

SK Life Science to Host Symposium and Present New Data at the American Epilepsy Society (AES) 2023 Annual Meeting

SK Life Science, Inc., a subsidiary of SK Biopharmaceuticals Co., Ltd., an innovative global pharmaceutical company focused on developing treatments for central nervous system (CNS) disorders and oncology, will present data on cenobamate at the American Epilepsy Society (AES) Annual Meeting, to be held December 1-5, 2023, in Orlando, Florida.

United statesUnited kingdomGregory kraussDanielle beckerLouis ferrariAngelini pharmaPavel kleinPatrick kwanOrange county convention centerAtlantic epilepsy sleep centerJohns hopkins university school of medicinebaltimoreOhio state university wexner medical centerSk biopharmaceuticals co ltdEuropean unionDepartment of neuroscience central clinical schoolSk life science inc

Catalyst Pharmaceuticals Announces Multiple Abstracts on FYCOMPA® (Perampanel) from Eisai Co, Ltd , to be Presented at the 35th International Epilepsy Congress

CORAL GABLES, Fla., Aug. 14, 2023 Catalyst Pharmaceuticals, Inc. , a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing and commercializing novel. -Today at 08:06 am- MarketScreener

United statesGary ingenitoPavel vlasovYotin chinvarunRicardo sainz fuertesClaudio liguoriStella ngoPatricia penovichAdam strzelczykGu leeMichael chezVadim kharkovskiyBernhardj steinhoffTony wuMotoki inajiOmar samad